All News

Gene Therapy

Oxford Biomedica Acquires ABL Europe from Institut Mérieux
6 December 2023
Oxford Biomedica Acquires ABL Europe from Institut Mérieux
Oxford Biomedica Acquires ABL Europe
Texas Children’s Hospital First to Deliver a Novel Gene Therapy for Rett Syndrome
5 December 2023
Texas Children’s Hospital First to Deliver a Novel Gene Therapy for Rett Syndrome
Two female pediatric patients with
20 Years of Advanced Therapies with David McCall: a Retrospective on Phacilitate’s Founding and Evolution of the Industry
4 December 2023
20 Years of Advanced Therapies with David McCall: a Retrospective on Phacilitate’s Founding and Evolution of the Industry
Lee Buckler, SVP Advanced Therapies,
FDA Investigating ‘Serious Risk’ of Secondary Malignancy Linked to BCMA- or CD19-Directed CAR-T Immunotherapies
29 November 2023
FDA Investigating ‘Serious Risk’ of Secondary Malignancy Linked to BCMA- or CD19-Directed CAR-T Immunotherapies
FDA investigates T cell malignancy
POPULAR NEWS ITEMS
Image
4 December 2023

20 Years of Advanced Therapies with David McCall: a Retrospective on Phacilitate’s Founding and Evolution of the Industry

Image
6 December 2023

Oxford Biomedica Acquires ABL Europe from Institut Mérieux

Image
5 December 2023

Texas Children’s Hospital First to Deliver a Novel Gene Therapy for Rett Syndrome

Navigating the Future of CGT Manufacturing: Exploring Challenges and Innovations in Manufacturing Science and Technology (MSAT)
28 November 2023
Navigating the Future of CGT Manufacturing: Exploring Challenges and Innovations in Manufacturing Science and Technology (MSAT)
In this interview David Sourdive
Sernova’s Hemophilia A Program Receives Orphan Drug and Rare Pediatric Disease Designations from FDA
28 November 2023
Sernova’s Hemophilia A Program Receives Orphan Drug and Rare Pediatric Disease Designations from FDA
Sernova has announced that the
20 Years of Advanced Therapies with Stefanos Theoharis: Sticking with CGT Through Technical & Technological Advancement
27 November 2023
20 Years of Advanced Therapies with Stefanos Theoharis: Sticking with CGT Through Technical & Technological Advancement
Stefanos Theoharis, CBO, Kiji Therapeutics
Positive Clinical Results in Myotubular Myopathy Demonstrate Impact on Respiratory and Motor Functions Amidst Severe Challenges
23 November 2023
Positive Clinical Results in Myotubular Myopathy Demonstrate Impact on Respiratory and Motor Functions Amidst Severe Challenges
Clinical results of a gene
Load more News
RECOMENDED TOPICS
Allogeneic
Autologous
CAR-X
Cell Therapy
Cell-Based IO
Gene Editing
Gene Therapy
NKx
Stem Cells
Tissue Engineering
Viral/Non-Viral Vectors
POPULAR NEWS ITEMS
Image

20 Years of Advanced Therapies with David McCall: a Retrospective on Phacilitate’s Founding and Evolution of the Industry

Image

Oxford Biomedica Acquires ABL Europe from Institut Mérieux

Image

Texas Children’s Hospital First to Deliver a Novel Gene Therapy for Rett Syndrome